(Q34657384)

3 August 2017

title

Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure (English)

1 reference

3 August 2017

1 reference

1 reference

coronary artery disease

1 reference

Katarzyna Jakubowska

7

0 references

Andrzej Ciechanowicz

Andrzej Ciechanowicz

12

0 references

Krzysztof Safranow

Krzysztof Safranow

1

0 references

Maria Olszewska

Maria Olszewska

8

0 references

Dariusz Chlubek

13

Dariusz Chlubek

1 reference

3 August 2017

9

Beata Loniewska

1 reference

Zdzisława Kornacewicz-Jach

3 August 2017

11

Zdzislawa Kornacewicz-Jach

1 reference

3 August 2017

6

Andrzej Wojtarowicz

1 reference

3 August 2017

2

Edyta Czyzycka

1 reference

3 August 2017

Agnieszka Binczak-Kuleta

3

Agnieszka Binczak-Kuleta

1 reference

3 August 2017

Ryszard Rzeuski

4

1 reference

3 August 2017

Janusz Skowronek

5

1 reference

3 August 2017

Robert Kaliszczak

10

1 reference

3 August 2017

publication date

1 January 2009

1 reference

Scandinavian Journal of Clinical and Laboratory Investigation

3 August 2017

published in

1 reference

3 August 2017

volume

69

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

102-112

1 reference

Molecular basis of AMP deaminase deficiency in skeletal muscle

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

Disruption of the purine nucleotide cycle. A potential explanation for muscle dysfunction in myoadenylate deaminase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

Variation in the gene for muscle-specific AMP deaminase is associated with insulin clearance, a highly heritable trait

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

Performing the exact test of Hardy-Weinberg proportion for multiple alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

Mitochondria and diabetes. Genetic, biochemical, and clinical implications of the cellular energy circuit

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: A study in 686 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510802430964

10.1080/00365510802430964

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference